COM:KYMERATX
Kymera Therapeutics, Inc.
- Stock
Last Close
43.51
22/11 21:00
Market Cap
2.22B
Beta: -
Volume Today
559.06K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|
average inventory | -81.69M - | -86.19M 5.50% | -10.62M 87.68% | -6.13M 42.33% | |||
average payables | 2.67M - | 3.82M 43.36% | 4.19M 9.54% | 4.17M 0.39% | 5.71M 36.81% | ||
average receivables | 74K - | 716.50K 868.24% | 784K 9.42% | 1.34M 70.41% | 8.77M 556.32% | ||
book value per share | -1.71 - | -2.46 44.11% | 16.36 764.03% | 9.58 41.46% | 9.09 5.11% | 0.01 99.93% | |
capex per share | -0.07 - | -0.02 73.83% | -0.52 2,875.68% | -0.03 93.65% | -0.05 58.01% | -0.00 98.88% | |
capex to depreciation | -6.61 - | -0.64 90.25% | -5.16 700.09% | -0.67 87.09% | -0.95 42.99% | -9.67 915.27% | |
capex to operating cash flow | 0.08 - | -0.03 139.14% | -0.10 247.37% | 0.01 112.00% | 0.02 49.58% | 0.34 1,710.05% | |
capex to revenue | -0.18 - | -0.27 47.40% | -0.02 91.80% | -0.06 176.21% | -0.44 624.39% | ||
cash per share | 2.05 - | 3.05 48.65% | 17.07 460.60% | 9.22 46.00% | 7.55 18.11% | 0.01 99.91% | |
days of inventory on hand | |||||||
days payables outstanding | |||||||
days sales outstanding | 15.37 - | 0.68 95.60% | 19.78 2,822.95% | 69.66 252.27% | |||
debt to assets | 0.02 - | 0.18 1,055.73% | 0.04 79.66% | 0.03 19.73% | 0.03 3.05% | 0.15 411.68% | |
debt to equity | -0.02 - | -0.28 1,311.28% | 0.06 122.25% | 0.04 38.34% | 0.04 9.50% | 0.21 506.17% | |
dividend yield | |||||||
earnings yield | -0.03 - | -0.04 28.29% | -0.04 0.64% | -0.03 21.27% | -0.11 250.67% | -0.00 99.91% | |
enterprise value | 629.27M - | 949.47M 50.88% | 1.06B 11.92% | 3.02B 183.89% | 1.30B 57.07% | 1.49T 114,635.92% | |
enterprise value over ebitda | -29.62 - | -23.52 20.60% | -23.37 0.64% | -30.16 29.05% | -8.38 72.23% | -8.98K 107,082.05% | |
ev to operating cash flow | -35.23 - | 53.03 250.53% | 12.06 77.26% | -23.40 294.03% | -8.46 63.84% | -14.45K 170,716.22% | |
ev to sales | 323.61 - | 31.22 90.35% | 41.42 32.66% | 27.66 33.23% | 18.91K 68,260.96% | ||
free cash flow per share | -0.95 - | 0.58 160.29% | 4.56 691.75% | -2.72 159.72% | -2.89 6.28% | -0.00 99.92% | |
free cash flow yield | -0.03 - | 0.02 160.29% | 0.07 324.73% | -0.04 158.31% | -0.12 170.33% | -0.00 99.92% | |
graham net net | -1.85 - | -3.28 77.31% | 0.71 121.58% | 6.08 757.82% | 5.38 11.57% | 0.00 99.93% | |
graham number | 6.40 - | 8.71 35.97% | 30.54 250.70% | 20.98 31.30% | 23.99 14.37% | 0.02 99.92% | |
income quality | 0.83 - | -0.43 152.17% | -1.93 345.28% | 1.29 166.56% | 0.99 23.14% | 0.70 29.24% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | |
interest coverage | -1.34K - | -917.50 31.56% | -402.64 56.12% | -574.46 42.67% | -916.23 59.49% | 844.54 192.18% | |
interest debt per share | 0.04 - | 0.70 1,892.38% | 1.04 48.38% | 0.38 63.79% | 0.32 14.10% | 0.00 99.55% | |
inventory turnover | |||||||
invested capital | -0.02 - | -0.28 1,311.28% | 0.06 122.25% | 0.04 38.34% | 0.04 9.50% | 0.21 506.17% | |
market cap | 669.83M - | 1.00B 49.93% | 1.08B 7.11% | 3.05B 183.25% | 1.35B 55.82% | 1.49T 110,285.90% | |
net current asset value | -36.88M - | -98.26M 166.46% | 99.05M 200.80% | 421.34M 325.37% | 446.51M 5.97% | 224.53M 49.71% | |
net debt to ebitda | 1.91 - | 1.36 28.88% | 0.29 78.93% | 0.30 4.86% | 0.33 10.07% | 0.15 53.73% | |
net income per share | -1.07 - | -1.37 28.29% | -2.53 85.22% | -2.04 19.38% | -2.82 37.86% | -0.00 99.91% | |
operating cash flow per share | -0.89 - | 0.59 166.85% | 5.08 756.64% | -2.69 152.90% | -2.84 5.64% | -0.00 99.94% | |
payables turnover | |||||||
receivables turnover | 23.75 - | 539.50 2,171.55% | 18.46 96.58% | 5.24 71.61% | |||
research and ddevelopement to revenue | 12.66 - | 1.82 85.59% | 1.88 3.10% | 3.51 86.45% | 2.41 31.41% | ||
return on tangible assets | -0.49 - | -0.35 27.10% | -0.09 74.51% | -0.16 79.30% | -0.25 55.65% | -0.26 1.40% | |
revenue per share | 0.10 - | 1.96 1,918.83% | 1.52 22.63% | 0.87 42.79% | 0.00 99.84% | ||
roe | 0.62 - | 0.55 10.98% | -0.15 127.89% | -0.21 37.73% | -0.31 45.29% | -0.37 20.12% | |
roic | 0.65 - | 1.32 103.28% | -0.14 110.57% | -0.20 42.17% | -0.30 51.92% | -0.29 2.66% | |
sales general and administrative to revenue | 2.72 - | 0.54 80.31% | 0.50 6.85% | 0.94 87.59% | 0.70 25.19% | ||
shareholders equity per share | -1.71 - | -2.46 44.11% | 16.36 764.03% | 9.58 41.46% | 9.09 5.11% | 0.01 99.93% | |
stock based compensation to revenue | 0.41 - | 0.15 62.59% | 0.34 124.84% | 0.76 120.99% | 0.55 27.59% | ||
tangible asset value | -34.44M - | -74.41M 116.07% | 283.89M 481.54% | 459.64M 61.91% | 490.15M 6.64% | 394.97M 19.42% | |
tangible book value per share | -1.71 - | -2.46 44.11% | 16.36 764.03% | 9.58 41.46% | 9.09 5.11% | 0.01 99.93% | |
working capital | 37.10M - | 58.27M 57.06% | 191.72M 229.00% | 466.57M 143.36% | 496.23M 6.36% | 319.63M 35.59% |
All numbers in (except ratios and percentages)